Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1392891 | European Journal of Medicinal Chemistry | 2012 | 13 Pages |
We have discovered and demonstrated the in vitro and in vivo PPARδ-selective activity of novel Y-shaped agonists. These compounds activated hPPARδ with EC50 values between 1 and 523 nM. Surprisingly, compounds 10a, 11d, 11e and 11f were the most potent and most selective hPPARδ agonists with 104-fold selectivity over the other two subtypes, namely, hPPARα and hPPARγ. The PPARδ ligands 10a, 11e and 11f showed good bioavailability and in vivo efficacy.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slideHighlights► We synthesized a series of Y-shaped analogs with alkyl and arylalkyl substituents. ► Compounds 10a, 11d, 11e and 11f displayed excellent selectivity and potency. ► Selective PPARδ agonists showed good bioavailability and in vivo efficacy.